OneSource Specialty Pharma Live Share Price Today, Share Analysis and Chart

Name: OneSource Specialty Pharma Ltd.: Is Infosys Ltd. worth buying?
Item: OneSource Specialty Pharma Ltd.
Rating: 2.033041625
Author: Trendlyne DVM scores

Expensive Performer

about

OneSource Specialty Pharma is engaged in the research, development, manufacture and commercialisation of biological drug products in various injectable formats. OneSource also offers end-to-end Contract Development and Manufacturing Operations servic...

1754.90 -14.70 (-0.83%)

45.04% Gain from 52W Low

21,783

NSE+BSE Volume

NSE 30 Dec, 2025 10:33 AM (IST)

Loading... You have run out of DVM views!

Subscribe now to see details

Medium Financial Strength

- / 100

Expensive Valuation

- / 100

Technically Neutral

47.3 / 100

Expensive Performer These stocks have medium quality and momentum.Their expensive valuations suggest caution View Similar Embed DVM

2,531

1Yr Price target upside is 44%

4 analysts

OneSource Specialty Pharma Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

OneSource Specialty Pharma Live Share Price Today, Share Analysis and Chart

OneSource Specialty Pharma is engaged in the research, development, manufacture and commercialisation of biological drug products in various injectable formats. OneSource also offers end-to-end Contract Development and Manufacturing Operations servic...

45.04% Gain from 52W Low

SWOT Analysis

OneSource Specialty Pharma Live Price Chart